Maryland Team Wins First Phase of NEI Contest to Create Human Retina

October 6, 2017: By Jon Swedien
Erin Lavik, ScD

Erin Lavik, ScD

A team from the University of Maryland, Baltimore County, beat out 12 other entries to win the first phase of a National Eye Institute (NEI) contest to create a living model of the human retina.

The NEI, part of the National Institutes of Health, announced the winner Sept. 28. The honor included a prize of $90 thousand.

The NEI’s 3-D Retina Organoid Challenge (3-D ROC) initiative seeks to design human retinas from stem cells. The submissions were evaluated based on their innovativeness and feasibility, the NEI said.

The winning concept was a proposal to build a retina by screen printing adult neural progenitor-derived retinal neurons in layers that mimic the structure of the human retina. The system is designed to be scalable, efficient, and reproducible, enabling high-throughput screening for drug testing, the NEI said. Erin Lavik, ScD, led the winning team.

The NEI plans to launch a second phase of the contest this fall and to award a combined total of $1 million to teams that demonstrate the functionality of a retina organoid prototype. Further details on the challenge will be provided in an official announcement, NEI said.

NEI also awarded five teams with an honorable mention. They were led by:

–Rebecca Carrier, PhD, Northeastern University, Boston;

–David Gamm, MD, PhD, University of Wisconsin, Madison;

–Wei Liu, PhD, Albert Einstein College of Medicine, Bronx, New York;

–Daniel Pelaez, PhD, University of Miami, Florida;

–Katja Schenke-Layland, PhD, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility